Herbal Dispatch announced today that it is accelerating its U.S. market plans in response to the U.S. HHS recommendation to move cannabis from Schedule I to Schedule III. This potential reclassification, if finalized by the DEA, would remove the Section 280E tax burden, improve access to banking and institutional capital, and support broader industry growth.
Key points from the update:
- The company is evaluating strategic partnerships, joint ventures, and platform distribution opportunities in the U.S. with a focus on medical cannabis channels.
- Herbal Dispatch plans to leverage its experience in patient acquisition, veteran programs, and direct-to-consumer medical sales from its Canadian operations.
- Its asset-light, tech-enabled e-commerce model is designed for efficient scaling with lower capital requirements.
- Already listed on OTCQB (LUFFF) with recent DTC eligibility, which should help with U.S. investor access and liquidity.
The company has built a solid base in Canada through its craft cannabis e-commerce platform and continues to focus on growth there while preparing for U.S. opportunities. This looks like a measured approach to position for potential regulatory changes. Worth watching if you're following cannabis stocks. What are your thoughts on this one?
Anyone following $HERB / $LUFFF?